v3.26.1
Discontinued Operations (Tables)
 9 Months Ended
Jun. 30, 2026
Discontinued Operations and Disposal Groups [Abstract]  
Schedule of Disposal Groups The following table presents the financial results of the B Medical Systems business, included within discontinued operations (in thousands):
Three Months Ended June 30,Nine Months Ended June 30,
2026202520262025
Revenue
Products$9,249 $14,333 $39,529 $44,507 
Services1,451 1,969 7,067 6,592 
Total revenue10,700 16,302 46,596 51,099 
Cost of revenue
Products5,671 9,793 26,937 31,333 
Services3,159 1,600 8,849 6,321 
Total cost of revenue8,830 11,393 35,786 37,654 
Gross profit1,870 4,909 10,810 13,445 
Operating expenses
Research and development1,301 1,533 4,024 4,369 
Selling, general and administrative3,538 6,939 12,441 20,855 
(Gain) loss on assets held for sale(6,474)60,858 9,491 92,706 
Restructuring charges135 373 434 1,051 
Total operating (income) expenses(1,500)69,703 26,390 118,981 
Operating income (loss)3,370 (64,794)(15,580)(105,536)
Interest income (expense), net— (10)1 (20)
Other income (expense), net65 (92)1,231 (166)
Income (loss) before income taxes3,435 (64,896)(14,348)(105,722)
Income tax expense (benefit)1,163 (17,542)(3,138)(26,959)
Income (loss) from discontinued operations, net of tax$2,272 $(47,354)$(11,210)$(78,763)
Schedule of Disposal Groups - Non-cash Items
The following table presents the significant non-cash items and capital expenditures with respect to the B Medical Systems business that are included in the Condensed Consolidated Statements of Cash Flows (in thousands):
Three Months Ended June 30,Nine Months Ended June 30,
2026202520262025
Depreciation and amortization$— $— $— $3,846 
Capital expenditures381 1,472 1,326 2,600 
(Gain) loss on assets held for sale(6,474)60,858 9,491 92,706 
Schedule of Disposal Groups - Balance Sheet
The carrying value of the assets and liabilities of the discontinued operations with respect to the B Medical Systems business reflected as “held for sale” on the Condensed Consolidated Balance Sheets as of June 30, 2026 and September 30, 2025 was as follows (in thousands):
June 30, 2026September 30, 2025
Assets
Cash and cash equivalents$8,363 $13,206 
Accounts receivable, net6,998 10,090 
Inventories43,109 42,137 
Prepaid expenses and other current assets12,917 8,102 
Current assets held for sale$71,387 $73,535 
Property, plant and equipment, net$50,673 $50,968 
Intangibles, net122,530 126,065 
Other assets6,835 4,828 
Valuation allowance(103,349)(96,855)
Noncurrent assets held for sale$76,689 $85,006 
Liabilities
Accounts payable$11,307 $11,710 
Deferred revenue1,371 1,543 
Accrued warranty and retrofit costs5,785 5,248 
Accrued compensation and benefits5,179 3,909 
Accrued income taxes732 760 
Accrued expenses and other current liabilities4,952 5,098 
Current liabilities held for sale$29,326 $28,268 
Long-term deferred tax liabilities8,275 9,639 
Long-term operating lease liabilities3,218 2,077 
Other long-term liabilities1,487 2,575 
Noncurrent liabilities held for sale$12,980 $14,291